|
TOR1A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.354100E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.461000E-03 |
| Normal-vs-Stage2 |
5.127600E-02 |
| Normal-vs-Stage3 |
4.759300E-04 |
| Normal-vs-Stage4 |
2.79319999996197E-06 |
| Stage1-vs-Stage2 |
7.350800E-01 |
| Stage1-vs-Stage3 |
1.129390E-01 |
| Stage1-vs-Stage4 |
2.737100E-03 |
| Stage2-vs-Stage3 |
5.383600E-01 |
| Stage2-vs-Stage4 |
8.518400E-02 |
| Stage3-vs-Stage4 |
1.318800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.030500E-04 |
| Normal-vs-AfricanAmerican |
2.850800E-01 |
| Normal-vs-Asian |
1.122950E-03 |
| Caucasian-vs-AfricanAmerican |
2.768000E-01 |
| Caucasian-vs-Asian |
7.142800E-01 |
| AfricanAmerican-vs-Asian |
2.230600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.245800E-04 |
| Normal-vs-Female |
8.162700E-04 |
| Male-vs-Female |
4.726800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.945770E-02 |
| Normal-vs-Age(41-60Yrs) |
4.024100E-04 |
| Normal-vs-Age(61-80Yrs) |
9.65640000000212E-05 |
| Normal-vs-Age(81-100Yrs) |
1.925050E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.334240E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.713900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.290800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.602600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.767800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.579000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.209400E-01 |
| Classical-VS-Follicular |
1.566820E-01 |
| Classical-VS-Other |
4.382200E-01 |
| Classical-VS-Normal |
1.337860E-03 |
| Tall-VS-Follicular |
4.715900E-02 |
| Tall-VS-Other |
8.929400E-01 |
| Tall-VS-Normal |
6.403500E-04 |
| Follicular-VS-Other |
3.227600E-01 |
| Follicular-VS-Normal |
1.857960E-01 |
| Other-VS-Normal |
2.285600E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.963500E-03 |
| Normal-vs-N1 |
1.75367999999398E-05 |
| N0-vs-N1 |
1.809880E-02 |
|
|
